Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia

Go back to Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia
(NASDAQ: BNGO) Delayed: 1.21 -0.02 (1.63%)
Previous Close $1.23    52 Week High
Open $1.22    52 Week Low
Day High $1.24    P/E N/A 
Day Low $1.19    EPS
Volume 111,437